Reaction
Subcutaneous Haematoma reporting signals
As of the last recalculation, Subcutaneous Haematoma appears in 1,266 FAERS reports alongside 14 co-occurring drug terms. The strongest observed disproportionality signal is FONDAPARINUX SODIUM (PRR 62.4).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Fondaparinux Sodium | 30 | 62.4 | 62.6 |
| Dalteparin Sodium | 19 | 30.0 | 30.0 |
| Alteplase | 26 | 29.0 | 29.1 |
| Rivaroxaban | 197 | 18.2 | 18.3 |
| Enoxaparin Sodium | 46 | 13.6 | 13.6 |
| Prasugrel Hydrochloride | 8 | 13.0 | 13.0 |
| Warfarin Sodium | 33 | 12.0 | 12.0 |
| Rifampin | 9 | 10.2 | 10.2 |
| Dabigatran Etexilate Mesylate | 43 | 10.0 | 10.0 |
| Ticagrelor | 19 | 9.9 | 9.9 |
| Dabigatran Etexilate | 45 | 9.8 | 9.8 |
| Pitavastatin Calcium | 6 | 9.7 | 9.7 |
| Emicizumab | 6 | 8.0 | 8.0 |
| Methoxy Polyethylene Glycol-Epoetin Beta | 5 | 7.5 | 7.5 |